A Clinical Trial to assess the Effectiveness of Facial Gun Massaging Therapy and Transcutaneous Electrical Nerve Stimulation for Myofascial Pain Dysfunction Syndrome Patients

A Comparative Study of Facial Gun Massaging Therapy and Transcutaneous Electrical Nerve Stimulation as an adjunct to Pharmaceutical Therapy for Myofascial Pain Dysfunction Syndrome: A Randomised Clinical Trial - NIL

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/02/080696

Enrollment

Registered

2025-02-17

Start date

Unknown

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M629- Disorder of muscle, unspecified

Interventions

Intervention1: Facial Gun Massaging Therapy+ Pharmacotheray: Group 2: 20 Patients

receive facial gun massaging therapy along with Pharmacotherapy TAB. MYOSPAS FORTE 0-0-1 for 1week through oral route

(Chlorzoxazone 500mg + Diclofenac Potassium 50mg + Paracetamol 325mg). Facial gun is used at a frequency of 30 Hz for 15 minutes given Biweekly for 5 weeks (10 sessions) Control Intervention1: Pharmac

receive Pharmacotherapy alone TAB. MYOSPAZ FORTE 0-0-1 for 1week through oral route (Chlorzoxazone 500mg + Diclofenac Potassium 50mg + Paracetamol 325mg). Control Intervention2: Transcutaneous Electri

receive Transcutaneous Electrical Nerve Stimulation along with Pharmacotherapy TAB. MYOSPAS FORTE 0-0-1 for 1week through oral route

(Chlorzoxazone 500mg + Diclofenac Potassium 50mg + Paracetamol 325mg). Transcutaneous Electrical Nerve Stimulation is used 180 Hz, 20 minutes given Biweekly for 5 weeks (10 sessions)

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age between 18 to 60 years. 2.Pain on palpation in masticatory muscles 3.Normal posterior occlusion. 4.Suffering from orofacial pain for a minimum of 1 months

Exclusion criteria

Exclusion criteria: 1.Presence of TMD with joint origin 2.Neuropathic pain. 3.Systemic diseases such as cardiovascular disorders, infectious diseases, inflammatory diseases, epilepsy, tumors, or mental illnesses which could affect the clinical picture of patients, 4.Removable denture, missing of more than one tooth in each quadrant, 5.Major malocclusion (anterior open bite, maxillary unilateral lingual cross-bite, and overjet greater than 6 mm)

Design outcomes

Primary

Measure	Time frame
Comparing the effectiveness of facial gun and TENS as an adjunct to Pharmaceutical Therapy for Myofascial Pain Dysfunction Syndrome patients. Timepoint: 2 months	—

Secondary

Measure	Time frame
To assess the pain in Group 2 MPDS patients undertaking Facial Gun Massaging Therapy as an adjunct to Pharmaceutical Therapy.Timepoint: 2 months;To assess the pain in Group 3 MPDS patients undertaking Transcutaneous Electrical Nerve Stimulation as an adjunct to Pharmaceutical Therapy.Timepoint: 2 months;To assess the pain in Group 1 MPDS patients undertaking Pharmaceutical Therapy alone.Timepoint: 2 months	—

Measure

Time frame

To assess the pain in Group 2 MPDS patients undertaking Facial Gun Massaging Therapy as an adjunct to Pharmaceutical Therapy.Timepoint: 2 months;To assess the pain in Group 3 MPDS patients undertaking Transcutaneous Electrical Nerve Stimulation as an adjunct to Pharmaceutical Therapy.Timepoint: 2 months;To assess the pain in Group 1 MPDS patients undertaking Pharmaceutical Therapy alone.Timepoint: 2 months

—

Countries

India

Contacts

Public ContactDr R R Mahendra Raj

Karpaga Vinayaga Institute of Dental Sciences

drmahendraraj@yahoo.com9789055848

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026